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1395 Robotic mitral valve surgery: A United States multicenter trial
L. Wiley Nifong, MD, W. R. Chitwood, MD, P. S. Pappas, MD, C. R. Smith, MD,
M. Argenziano, MD, V. A. Starnes, MD, and P. M. Shah, MD, for the Multi-center Robotic
Mitral Repair Group, Greenville, NC, Oak Lawn, Ill, New York, NY, and Los Angeles and
Newport Beach, Calif
A phase II multicenter robotic MV repair trial was completed. Ten centers in the United States
enrolled 112 patients. Six patients required reoperations for recurrent MR. This multicenter
study shows that MV repairs can be performed safely, with significant patient benefits, by
multiple surgeons and teams.
1405 Modulation of phosphatidylinositol 3-kinase signaling reduces intimal
hyperplasia in aortocoronary saphenous vein grafts
Jonathan A. Hata, MD, Jason A. Petrofski, MD, Jacob N. Schroder, MD,
Matthew L. Williams, MD, Sarah H. Timberlake, BS, Anne Pippen, BS,
Michael T. Corwin, MD, Amy K. Solan, MS, Andre Jakoi, BS, Thomas R. Gehrig, MD,
Christopher D. Kontos, MD, and Carmelo A. Milano, MD, Durham, NC, and Boston, Mass
Intimal hyperplasia (IH) is responsible for saphenous vein graft occlusion after aortocoronary
bypass and is marked by vascular smooth muscle cell proliferation. Adenovirus-mediated
expression of PTEN (phosphatase and tensin homolog deleted on chromosome 10) in canine
aortocoronary vein grafts inhibits the development of IH, suggesting this pathway might
represent a novel therapeutic target.
1414 Normalization of coronary microvascular reactivity and improvement in
myocardial perfusion by surgical vascular endothelial growth factor therapy
combined with oral supplementation of L-arginine in a porcine model of
endothelial dysfunction
Pierre Voisine, MD, Cesario Bianchi, MD, PhD, Tanveer A. Khan, MD, Marc Ruel, MD, MPH,
Shu-Hua Xu, PhD, Jun Feng, MD, PhD, Jian Li, MD, PhD, Tamer Malik, MD,
Audrey Rosinberg, MD, and Frank W. Sellke, MD, Boston, Mass
In a porcine model of hypercholesterolemia-induced endothelial dysfunction and chronic
myocardial ischemia, oral supplementation with L-arginine restored normal coronary
microvascular endothelium-dependent vasorelaxation and angiogenic response to exogenous
vascular endothelial growth factor.
Cardiothoracic
Transplantation
(TX)
1421 Primary graft dysfunction and other selected complications of lung
transplantation: A single-center experience of 983 patients
Bryan F. Meyers, MD, Maite de la Morena, MD, Stuart C. Sweet, MD, Elbert P. Trulock, MD,
Tracey J. Guthrie, RN, BSN, Eric N. Mendeloff, MD, Charles Huddleston, MD,
Joel D. Cooper, MD, and G. Alexander Patterson, MD, St Louis, Mo
A review of 983 lung transplantations included 277 children and 706 adults. Mortality was 96
(9.8%) of 983, including 46 (17%) of 277 in children and 50 (7%) of 706 in adults. Causes of
death included BOS, respiratory failure, and infection. The frequency of primary graft
dysfunction did not differ between children and adults. Despite differences in diagnoses and
techniques, the patients had similar outcomes.
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